WO2024003788 - TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH ALTERNATING ELECTRIC FIELDS
National phase entry is expected:
Publication Number
WO/2024/003788
Publication Date
04.01.2024
International Application No.
PCT/IB2023/056717
International Filing Date
28.06.2023
Title **
[English]
TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH ALTERNATING ELECTRIC FIELDS
[French]
TRAITEMENT DU SYNDROME DE DÉTRESSE RESPIRATOIRE AIGUË AVEC DES CHAMPS ÉLECTRIQUES ALTERNATIFS
Applicants **
NOVOCURE GMBH
Inventors
GILADI, Moshe
Priority Data
63/356,590
29.06.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2427 | |
| EPO | Filing, Examination, Granting | 15311 | |
| Japan | Filing, Examination, Granting | 2618 | |
| South Korea | Filing, Examination, Granting | 2902 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
30,398
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A method of treating acute respiratory distress syndrome (ARDS) in a subject by applying an alternating electric field (AEF) to a region of the subject's torso. The ARDS may be caused by sepsis, viral infection, bacterial infection, near-drowning, chemical inhalation, acute pancreatitis, and chest injury. The viral infection may be COVID-19 or long covid. The ARDS may be identified using the Berlin Definition.[French]
L'invention concerne une méthode de traitement du syndrome de détresse respiratoire aiguë (SDRA) chez un patient par application d'un champ électrique alternatif à une région du torse du patient. Le SDRA peut être provoqué par une sepsie, une infection virale, une infection bactérienne, une quasi-noyade, une inhalation chimique, une pancréatite aiguë et une lésion thoracique. L'infection virale peut être la COVID-19 ou la covid longue. Le SDRA peut être identifié à l'aide de la définition de Berlin.